Related Experiment Video

Updated: Jul 10, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

HRK inactivation associated with promoter methylation and LOH in prostate cancer

Tomonori Higuchi1, Mitsutoshi Nakamura, Keiji Shimada

  • 1Department of Pathology, Nara Medical University School of Medicine, Nara, Japan.

The Prostate
|November 17, 2007
PubMed
Abstract

Insights

HRK gene promoter hypermethylation inactivates HRK in prostate cancer, leading to reduced expression and potentially promoting tumor progression by affecting apoptosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Reduced expression of the HRK gene has been observed in certain human tumors due to hypermethylation.
  • Prostate cancer research has not yet extensively investigated the methylation status of the HRK gene.

Purpose of the Study:

  • To investigate the methylation status of the HRK gene in prostate cancer.
  • To determine if HRK gene alterations correlate with other molecular changes and tumor characteristics.

Main Methods:

  • Analysis of HRK gene promoter hypermethylation and HRK protein/mRNA expression in 53 prostate cancer samples.
  • Assessment of 12q13.1 loss of heterozygosity (LOH), p53 mutations, and apoptotic indices using TUNEL assays.
  • Evaluation of methylation status for other genes including p14(ARF), p16(INK4a), O(6)-MGMT, and GTS-P.

Main Results:

  • 38% of prostate cancers exhibited HRK promoter or exon 1 hypermethylation.
  • Loss of HRK expression, detected in 14 cancers, was significantly associated with promoter methylation.
  • High apoptotic indices correlated with positive HRK expression, while HRK loss correlated with decreased apoptosis, particularly in lower Gleason scores.

Conclusions:

  • HRK gene inactivation in prostate cancer primarily occurs through promoter hypermethylation.
  • Decreased HRK expression may contribute to prostate cancer progression by influencing apoptotic cell death.

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Isolation and Cultivation of Neural Progenitors Followed by Chromatin-Immunoprecipitation of Histone 3 Lysine 79 Dimethylation Mark10:09

Isolation and Cultivation of Neural Progenitors Followed by Chromatin-Immunoprecipitation of Histone 3 Lysine 79 Dimethylation Mark

Published on: January 26, 2018

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...